ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0754

Clinical Characterization of Aortitis and Periaortitis in a Cohort of 134 Patients from a Single Universitary Center. A Model-based Cluster Analysis

Carmen Secada Gómez1, Javier Loricera2, Adrián Martín-Gutiérrez3, Fernando Lopez-Gutierrez4, María Nuñez-Sayar5, Ander Ucelay-Aristi5, Isabel Martinez-Rodriguez6, ivan Ferraz-Amaro7, Santos Castañeda8 and Ricardo Blanco-Alonso9, 1Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Hospital Universitario Marques de Valdecilla, IDIVAL, Renedo de Piélagos, Cantabria, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 5Cardiovascular Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 6Nuclear Medicine, Hospital Universitario Marques de Valdecilla,IDIVAL, Santander, Cantabria, Spain, 7Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 8Hospital Universitario de la Princesa, Madrid, Spain, 9Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

Meeting: ACR Convergence 2024

Keywords: giant cell arteritis, IgG4 Related Disease, Statistical methods, Takayasu.s arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Aortitis and periaortitis represent the inflammation of the aortic wall and the surrounding periaortic tissues, respectively. Both can be idiopathic or secondary to infectious and non-infectious processes, and, usually, have non-specific manifestations. Thus, early diagnosis is usually a challenge. Our aim was  to assess the causes and the main features of aortitis and periaortitis from a single university center ad to identify the different phenotypes using a cluster analysis.

Methods: Observational study of patients with aortitis or periaortitis from a referral center in Spain. A model-based cluster analysis was performed. Chi-square test was used to compare categorical variables among groups. Ward method was used to create a dendrogram of the hierarchical clustering leading to three clusters: C1 (asthenia), C2 (headache) and C3 (PmR).

Results: A total of 134 patients (87 female, 47 male) with a mean age of 55.1±9.1 years were included. 132 patients were diagnosed with aortitis and 2 with periaortitis. Aortitis was associated with giant cell arteritis (n=102), Takayasu arteritis (n=6), IgG4-related disease (n=6), infectious diseases (n=3), malignancy (n=1), drugs (n=1), isolated aortitis (n=1), and other immune-mediated inflammatory diseases (IMIDs) (n=12), including Sjögren syndrome (n=2), sarcoidosis (n=2), rheumatoid arthritis (n=2), axial spondyloarthritis (n=2), inflammatory bowel disease (n=1), primary biliary cirrhosis (n=1), idiopathic lung fibrosis (n=1) and polyarteritis nodosa (n=1). Periaortitis was due to idiopathic retroperitoneal fibrosis in both cases. Diagnostic imaging techniques used included 18F-FDG PET/CT scan (n=133), computed tomography angiography (CT-A) (n=44), and magnetic resonance imaging angiography (MRI-A) (n=33) (Table 1). The ascending thoracic aorta was the most frequently involved segment (78.8%) (Figure 1). The most common clinical manifestations were polymyalgia rheumatica (52.2%) and asthenia (53.7%), followed by limb claudication (23.9%) and inflammatory back pain (26.9%). Acute phase reactants were usually elevated. Three clusters were observed in patients with aortitis (not included periaortitis): C1 (60.6%), C2 (26.5%), and C3 (12.9%). General manifestations were predominant in C1, including asthenia (68.7%), weight loss (38.7%), and hyporexia (27.5%). Cranial ischemic manifestations were more frequent in C2, with headache (74.3%), temporal artery abnormalities (28.6%), jaw claudication (31.4%), and visual alterations (40%). Polymyalgia rheumatica was predominant across all clusters, ranging from 100% in C3 to 48.7% in C1. (Figure 2).

Conclusion: Aortitis is a relatively common condition associated with various underlying entities. Its clinical presentation is often non-specific, leading to frequent delays in diagnosis. Aortitis is highly heterogeneous, with diverse clinical manifestations. Cluster analysis can be used to identify clinical patterns.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: C. Secada Gómez: None; J. Loricera: AstraZeneca, 2, 6, Celgene, 2, 6, Eli Lilly, 5, Janssen, 5, Merck/MSD, 2, 5, 6, Novartis, 12, Formation/Congress attendance, Pfizer, 5, Roche, 2, 5, 6, UCB, 2, 5, 6; A. Martín-Gutiérrez: None; F. Lopez-Gutierrez: AstraZeneca, 12, Formation/Congress attendance, 12, Formation/Congress attendance, Novartis, 12, Formation/congress attendance; M. Nuñez-Sayar: None; A. Ucelay-Aristi: None; I. Martinez-Rodriguez: None; i. Ferraz-Amaro: AbbVie/Abbott, 5, 6, Celgene, 6, Janssen, 5, Merck/MSD, 5, 6, Pfizer, 6, Roche, 5, 6, sanofi, 6; S. Castañeda: Bristol-Myers Squibb(BMS), 2, 6, Eli Lilly, 2, 6, Merck/MSD, 2, 5, 6, Pfizer, 5, Roche, 2, 6, UCB, 2, 5; R. Blanco-Alonso: AbbVie, 2, 5, 6, Bristol-Myers Squibb, 2, 6, Galapagos, 6, Janssen, 2, 6, Lilly, 2, 6, MSD, 2, 5, 6, Pfizer, 2, 6, Roche, 2, 5, 6.

To cite this abstract in AMA style:

Secada Gómez C, Loricera J, Martín-Gutiérrez A, Lopez-Gutierrez F, Nuñez-Sayar M, Ucelay-Aristi A, Martinez-Rodriguez I, Ferraz-Amaro i, Castañeda S, Blanco-Alonso R. Clinical Characterization of Aortitis and Periaortitis in a Cohort of 134 Patients from a Single Universitary Center. A Model-based Cluster Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-characterization-of-aortitis-and-periaortitis-in-a-cohort-of-134-patients-from-a-single-universitary-center-a-model-based-cluster-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characterization-of-aortitis-and-periaortitis-in-a-cohort-of-134-patients-from-a-single-universitary-center-a-model-based-cluster-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology